Key result
Brugada syndrome patients face a ~13% risk of major arrhythmic events over eight years.
Why the study?
The clinical characteristics, treatment, long-term prognosis, and presence of Brugada electrocardiogram pattern in southern Chinese populations needed evaluation.
Cohort (n=80)
In a southern Chinese cohort, Brugada syndrome showed a low prevalence and low arrhythmic risk in asymptomatic patients, but fever was identified as a significant trigger for malignant arrhythmias, highlighting the need for aggressive fever management.
Fever may trigger events in Brugada syndrome; leaves open arrhythmic risk stratification in asymptomatic southern Chinese cohorts.
OBJECTIVE: To evaluate the presence of Brugada electrocardiogram (ECG) pattern, clinical characteristics, treatment, and long-term prognosis of Brugada syndrome in southern Chinese population. METHODS: This prospective study consisted of a consecutive series of patients with diagnostic coved type I Brugada ECG pattern at baseline between January 2007 and February 2020. Histories of symptoms including ventricular tachycardia (VT)/ventricular fibrillation (VF) episode, syncope, and family history of Brugada Syndrome (BrS) or unexplained sudden cardiac death were collected. Electrophysiological study and implantable cardioverter-defibrillator (ICD) were performed. All patients included in this study were followed up in the outpatient department every 6 months after baseline evaluation. Occurrences of syncope, VF, and sudden death were independently analyzed by two cardiologists. RESULTS: 45 (56.3%) patients were diagnosed with BrS. During a mean follow-up of 7.9 ± 3.6 years, six patients had experienced documented VF/sudden cardiac death (SCD) or recurrent syncope. Two patients experienced episodes of syncope more than once. Two patients experienced onset of electrical storm with a total of 11 episodes of VF. There were 50% of these events occurring in fever status. One of patient with BrS died of SCD. CONCLUSION: There was a very low prevalence of Brugada syndrome in southern Chinese population. The risk of arrhythmic events was low in asymptomatic patients. ICD was high effective in preventing SCD without adverse device outcome in long-term follow-up. Fever can lead to predispose to malignant arrhythmia, and aggressive treatment of febrile state in Brugada syndrome was recommended.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) conducted a cohort in Brugada Syndrome (n=80). Implantable cardioverter-defibrillator (ICD) and clinical follow-up was evaluated on Occurrences of syncope, ventricular fibrillation, and sudden death. During a mean follow-up of 7.9 years, 6 of 45 patients with Brugada syndrome experienced documented ventricular fibrillation, sudden cardiac death, or recurrent syncope.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: